Wellington Partners

Wellington Partners

  • Home
  • Team
  • Approach
  • Portfolio
  • News
  • Contact

News

Confo Therapeutics appoints Paolo Vicini as Chief Development Officer

Details
Published: 04 June 2020
  • portfolio-news

Confo Therapeutics today announced the appointment of Paolo Vicini in the newly-created position of CDO effective June 1, 2020.With two decades of leadership and scientific experience in pharmaceutical research and development, Dr. Vicini will apply his experience in translational and clinical sciences to support the Company as it moves its GPCR modulating small molecules through preclinical studies and into the clinic.

© Wellington Partners, 2021.
  • WP Technology Funds
  • Contact
  • Imprint
  • Privacy